Krajsová, Ivana: Komentář k článku: Ascierto P. A., McArthur G. A., Dréno B. et al. Cobimetinib combined with vemurafenib in advanced BRAF(V600)-mutant melanoma (coBRIM): update efficacy results from a randomised, double-blind, phase III trial. Lancet Oncol. 2016; 17: 1248-1260